# E-DRUG: Drugs use indicators in Zimbabwe (4)

**URL:** <https://talk.edrugplus.org/t/e-drug-drugs-use-indicators-in-zimbabwe-4/4147>\
**Category:** e-drug\
**Created:** [January 6, 1999, 3:07am UTC](https://talk.edrugplus.org/t/e-drug-drugs-use-indicators-in-zimbabwe-4/4147 "1999-01-06T03:07:12Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Francis\_Aboagye-Nyam](https://avatars.discourse-cdn.com/v4/letter/f/4af34b/32.png) [@Francis\_Aboagye-Nyam](https://talk.edrugplus.org/u/Francis_Aboagye-Nyam)\
**Post date:** [January 6, 1999, 3:07am UTC](https://talk.edrugplus.org/t/e-drug-drugs-use-indicators-in-zimbabwe-4/4147/1 "1999-01-06T03:07:12Z")

</div>

E-drug: Drugs use indicators in Zimbabwe (4)  
---------------------------------------------

This study sounds a good start of an interesting programme. Yes I agree  
that routine obstetric admission could usefully be discounted, or at least  
the sensitivity of the results to in/out tested. The issue then to define  
is what is routine?

I would be interested to know about the inter-hospital variation, or the  
inter-hospital group variation. For sure the dataset is small as yet, but  
that may yield useful targets.

Tim Dodd  
Training Advisor  
Ghana National Drugs Programme  
Ministry of Health  
P. O. Box MB-582  
Accra  
Tel/Fax: (233)-21-664309  
E-mail: gndp@ighmail.com

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
